TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33158423

Group type: EXPERIMENTAL
Intervention: Oral neuromuscular training with an oral device (Muppy®) for 5 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group with continued orofacial sensory-vibration stimulation with an electric toothbrush for 5 weeks
Number of subjects: 40
Study: 35150773

Group type: EXPERIMENTAL
Intervention: SCARF intervention (multidisciplinary residential rehabilitation)
Number of subjects: 0
Study: 33579525

Group type: EXPERIMENTAL
Intervention: Insulin stimulation in cultures of normal human granulosa cells in vitro
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Insulin concentration of 100 nmol/L for 12 hours
Number of subjects: 40
Study: 35729713

Group type: EXPERIMENTAL
Intervention: Ozoralizumab 30 mg
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: Ozoralizumab 80 mg
Number of subjects: 381

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 381
Study: 32179153

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine (ITM) 0.2 mg
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control (2 ml of 0.9% saline)
Number of subjects: 92
Study: 35370933

Group type: EXPERIMENTAL
Intervention: Individualized nursing and health education (INHE)
Number of subjects: 68
Study: 33241482

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (OT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (PLC)
Number of subjects: 0
Study: 34585222

Group type: EXPERIMENTAL
Intervention: Multi-domain intervention program including management of vascular risk factors, group-based physical exercise, nutritional counseling, and cognitive training
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Multi-domain intervention program
Number of subjects: 500

Group type: COMPARATOR
Intervention: Health-related information provided every two months
Number of subjects: 500
Study: 32507029

Group type: EXPERIMENTAL
Intervention: Pineapple juice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Water
Number of subjects: 0
Study: 34520637

Group type: EXPERIMENTAL
Intervention: Metacognitive therapy (MCT)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 39
Study: 32759439

Group type: EXPERIMENTAL
Intervention: Pectoral nerve block with ropivacaine 0.375% 30 ml
Number of subjects: 60

Group type: COMPARATOR
Intervention: Thoracic paravertebral block with ropivacaine 0.5% 20 ml
Number of subjects: 60
Study: 33092947

Group type: EXPERIMENTAL
Intervention: 10% lidocaine spray
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: 2% lidocaine gel
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: 4% lidocaine with xylometazoline (1:1) soaked pledgets
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Aqueous gel
Number of subjects: 376

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 376
Study: 32658083

Group type: EXPERIMENTAL
Intervention: Nomogram based on identified risk factors (male sex, smoking history, history of severe acute pancreatitis, chronic pain at/before diagnosis of ICP, complex pathologic changes in main pancreatic duct)
Number of subjects: 1633
Study: 35164853

Group type: EXPERIMENTAL
Intervention: Modified Bushen Yiqi formula (MBYF) as an add-on to budesonide/formoterol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo as an add-on to budesonide/formoterol
Number of subjects: 0
Study: 33111980

Group type: EXPERIMENTAL
Intervention: Ozone-autohemotherapy
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control
Number of subjects: 28
Study: 33558090

Group type: EXPERIMENTAL
Intervention: MiS coupled with VPA for predicting hot carcase P8 fat depth
Number of subjects: 1274

Group type: EXPERIMENTAL
Intervention: MiS coupled with VPA for predicting cold carcase rib fat
Number of subjects: 1274

Group type: EXPERIMENTAL
Intervention: MiS coupled with OCP for predicting hot carcase P8 fat depth
Number of subjects: 1274
Study: 33308429

Group type: COMPARATOR
Intervention: Monovalent OPV2 (1 or 2 doses)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Novel OPV2‐c1 (1 or 2 doses)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Novel OPV2‐c2 (1 or 2 doses)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Novel OPV2‐c1 (2 doses) in IPV-vaccinated participants
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Novel OPV2‐c2 (2 doses) in IPV-vaccinated participants
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo (2 doses) in IPV-vaccinated participants
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Novel OPV2 candidates (1 dose)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Monovalent OPV2 (1 dose)
Number of subjects: 300
Study: 33185706

Group type: EXPERIMENTAL
Intervention: Integrated deep learning and level set method for pulp chamber segmentation
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Integrated deep learning and level set method for age estimation
Number of subjects: 180
Study: 32472255

Group type: EXPERIMENTAL
Intervention: RT + GPS
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: GPS + RT
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: RT + Biodentine
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Biodentine + RT
Number of subjects: 72

Group type: COMPARATOR
Intervention: Intact/non-irradiated teeth
Number of subjects: 72
Study: 32857113

Group type: EXPERIMENTAL
Intervention: Cochlear implant
Number of subjects: 100
Study: 35441926

Group type: EXPERIMENTAL
Intervention: Active group with support tool app for medication intake reminders and motivational messages
Number of subjects: 676

Group type: COMPARATOR
Intervention: Control group without support tool app
Number of subjects: 676

Group type: COMPARATOR
Intervention: Both groups (active and control)
Number of subjects: 676

Group type: EXPERIMENTAL
Intervention: Active group
Number of subjects: 676

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 676
Study: 34903034

Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 3005

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 3005
Study: 34658033

Group type: EXPERIMENTAL
Intervention: Stimulation ON (n=8)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Stimulation OFF (n=10)
Number of subjects: 18
Study: 32831984

Group type: EXPERIMENTAL
Intervention: Preoperative intravenous infusion of 5 mg zoledronic acid (ZOL)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Control group (no ZOL)
Number of subjects: 242
Study: 36152527

Group type: EXPERIMENTAL
Intervention: Dry needling (DN)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Self-stretching
Number of subjects: 38
Study: 34453504

Group type: EXPERIMENTAL
Intervention: Low-frequency electro-acupuncture
Number of subjects: 54

Group type: COMPARATOR
Intervention: Sham acupuncture (control)
Number of subjects: 54
Study: 33528908

Group type: EXPERIMENTAL
Intervention: Weight loss following RYGB
Number of subjects: 1020
Study: 32669410

Group type: EXPERIMENTAL
Intervention: Waist circumference cut points of >102 cm in men
Number of subjects: 16289

Group type: EXPERIMENTAL
Intervention: Waist circumference cut points of >97 cm in women
Number of subjects: 16289

Group type: COMPARATOR
Intervention: Current JIS criteria for metabolic syndrome
Number of subjects: 16289
Study: 36172051

Group type: EXPERIMENTAL
Intervention: Phenylephrine (0.54 μg/kg/min)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Norepinephrine (0.08 μg/kg/min)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Metaraminol (2 μg/kg/min)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Phenylephrine
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Norepinephrine
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Metaraminol
Number of subjects: 78
Study: 32540434

Group type: EXPERIMENTAL
Intervention: NOBLE trial
Number of subjects: 0

Group type: COMPARATOR
Intervention: EXCEL trial
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MITRA-FR trial
Number of subjects: 0

Group type: COMPARATOR
Intervention: COAPT trial
Number of subjects: 0
Study: 32124657

Group type: EXPERIMENTAL
Intervention: Observing a novice model
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Observing an expert model
Number of subjects: 156

Group type: COMPARATOR
Intervention: Learning without a model
Number of subjects: 156

Group type: COMPARATOR
Intervention: Physical practice
Number of subjects: 156
Study: 32533796

Group type: COMPARATOR
Intervention: ATTACH intervention
Number of subjects: 20
Study: 35997325

Group type: EXPERIMENTAL
Intervention: Favipiravir (FPV) 1800 mg BID on Day 1 and 800 mg BID for 5-14 days thereafter
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Favipiravir (FPV)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control (supportive care only)
Number of subjects: 93
Study: 33781704

Group type: EXPERIMENTAL
Intervention: Early drain removal (Group 2) at 3-4 days postoperatively
Number of subjects: 49

Group type: COMPARATOR
Intervention: Output-based drain removal (Group 1)
Number of subjects: 49
Study: 32111892

Group type: EXPERIMENTAL
Intervention: IVB-before-PPV
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: PPV
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: IVB
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control (observation)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Surgical treatment (PPV)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: IVB injections
Number of subjects: 89
Study: 32631958

Group type: EXPERIMENTAL
Intervention: Fan therapy (table fan)
Number of subjects: 1

Group type: COMPARATOR
Intervention: Fan therapy
Number of subjects: 1
Study: 34247100

Group type: EXPERIMENTAL
Intervention: Endotoxin-removed recombinant MaINTL (rMaINTL) protein
Number of subjects: 0

Group type: COMPARATOR
Intervention: GST-tag proteins
Number of subjects: 0
Study: 34958382

Group type: EXPERIMENTAL
Intervention: 3 doses of 5 μg or 10 μg of a SARS-CoV-2 inactivated vaccine
Number of subjects: 500

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 500
Study: 34262261

Group type: EXPERIMENTAL
Intervention: 2.5 mg frovatriptan succinate tablet (single-dose)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 5 mg frovatriptan succinate tablet (single-dose)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 10 mg frovatriptan succinate tablet (single-dose)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 2.5 mg frovatriptan succinate tablet (multiple-dose, 12 times in 7 days)
Number of subjects: 24
Study: 32241790

Group type: EXPERIMENTAL
Intervention: Labral repair
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Biceps tenodesis
Number of subjects: 114

Group type: COMPARATOR
Intervention: Sham surgery
Number of subjects: 114
Study: 36094457

Group type: EXPERIMENTAL
Intervention: Active NMES (n = 21)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Sham NMES (n = 8)
Number of subjects: 64
Study: 34411221

Group type: EXPERIMENTAL
Intervention: DAS (implants with surface modified by double acid‐etching and sandblasting)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: DAS-H (implants with surface modified by double acid‐etching and sandblasting, stored in 0.9% saline solution)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group not explicitly mentioned
Number of subjects: 20
Study: 32948816

Group type: EXPERIMENTAL
Intervention: Straw mulching practices
Number of subjects: 0
Study: 35107429

Group type: EXPERIMENTAL
Intervention: Enhanced care (EC) with continuous glucose monitoring and low-carbohydrate nutrition counseling (<100 g/day)
Number of subjects: 1584

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 1584
Study: 34805204

Group type: EXPERIMENTAL
Intervention: Remimazolam Besylate
Number of subjects: 84

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 84
Study: 35699263

Group type: EXPERIMENTAL
Intervention: Therapy Program for Management of Chronic Cough (TMCC)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Comprehensive Vocal Rehabilitation Program (CVRP)
Number of subjects: 11
Study: 33764863

Group type: EXPERIMENTAL
Intervention: Microfracture for chondral defects (Group 1)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Defect debridement procedure only (Group 2)
Number of subjects: 55
Study: 36397102

Group type: EXPERIMENTAL
Intervention: Pharmacist-led medication review, patient counselling, and information transmission to general practitioners and community pharmacies after discharge
Number of subjects: 216

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 216
Study: 33086438

Group type: EXPERIMENTAL
Intervention: Ustekinumab 90 mg every 12 weeks (q12w)
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: Ustekinumab 90 mg every 8 weeks (q8w)
Number of subjects: 399

Group type: COMPARATOR
Intervention: Combined ustekinumab
Number of subjects: 399

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 399
Study: 35477563

Group type: EXPERIMENTAL
Intervention: Limosilactobacillus reuteri (Prodentis®‐lozenges, DSM 17938, ATCC PTA 5289)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control lozenges
Number of subjects: 68
Study: 33858775

Group type: EXPERIMENTAL
Intervention: Stress
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Depressive symptoms
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: HEI‐2015 total scores
Number of subjects: 228
Study: 36074747

Group type: EXPERIMENTAL
Intervention: Copper oxide wire particles (COWP) 2 g administered orally
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo control capsule
Number of subjects: 57
Study: 34078331

Group type: EXPERIMENTAL
Intervention: Apical patency maintained with a size 10 K-file during conventional hand filing step-back shaping procedure.
Number of subjects: 160

Group type: COMPARATOR
Intervention: Non-patency group (control).
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Vital teeth of patency-maintained group treated in multiple visits.
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Preoperative pain.
Number of subjects: 160
Study: 34791074

Group type: EXPERIMENTAL
Intervention: Fosfomycin (3g once daily for 10 days)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Ciprofloxacin (0.5g twice daily for 10 days)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Fosfomycin
Number of subjects: 97

Group type: COMPARATOR
Intervention: Ciprofloxacin
Number of subjects: 97
Study: 32711957

Group type: EXPERIMENTAL
Intervention: L + ICE (ice slurry ingestion)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: M + ICE (ice slurry ingestion)
Number of subjects: 10

Group type: COMPARATOR
Intervention: L + AMB (ambient water ingestion)
Number of subjects: 10

Group type: COMPARATOR
Intervention: M + AMB (ambient water ingestion)
Number of subjects: 10
Study: 36115574

Group type: EXPERIMENTAL
Intervention: Circuit walking, balance, cycling and strength training (CBCS) for 12 weeks
Number of subjects: 46

Group type: COMPARATOR
Intervention: Sociocultural activities for 12 weeks
Number of subjects: 46
Study: 34976613

Group type: EXPERIMENTAL
Intervention: Intervention 1 (information and attendance incentive)
Number of subjects: 1320

Group type: EXPERIMENTAL
Intervention: Intervention 2 (information, attendance incentives, personalized support)
Number of subjects: 1320

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1320

Group type: EXPERIMENTAL
Intervention: Regular users of the facility
Number of subjects: 1320

Group type: EXPERIMENTAL
Intervention: Increased frequency and duration of promotion
Number of subjects: 1320

Group type: EXPERIMENTAL
Intervention: Regular attendance
Number of subjects: 1320
Study: 35265302

Group type: EXPERIMENTAL
Intervention: Low-Level Laser Therapy (LLLT) combined with conventional physical therapy
Number of subjects: 110

Group type: COMPARATOR
Intervention: Conventional physical therapy alone
Number of subjects: 110
Study: 32299355

Group type: EXPERIMENTAL
Intervention: LPS (10 μg/ml)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Poly (I:C) (10 μg/ml)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heat-inactivated Vibrio harveyi (107 cell/ml)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LPS dose-increased treatment (0, 10, 20, and 50 μg/ml)
Number of subjects: 0
Study: 33419788

Group type: EXPERIMENTAL
Intervention: Optimel 16% manuka honey eye-drops
Number of subjects: 59

Group type: COMPARATOR
Intervention: Regular lubricants (control group)
Number of subjects: 59
Study: 34574794

Group type: EXPERIMENTAL
Intervention: multisport enriched PE
Number of subjects: 181

Group type: COMPARATOR
Intervention: control group
Number of subjects: 181
Study: 35595501

Group type: EXPERIMENTAL
Intervention: LUS‐BL‐guided intensive HF management
Number of subjects: 318

Group type: COMPARATOR
Intervention: Conventional HF management
Number of subjects: 318
Study: 33839197

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study: 32129194

Group type: COMPARATOR
Intervention: Alpha-keto analogue (600 mg tablet three times a day)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Alpha-keto analogue (600 mg tablet three times a day) + Nigella sativa oil (2.5 mL, per orally, once daily) for 12 weeks
Number of subjects: 150
Study: 36057171

Group type: EXPERIMENTAL
Intervention: Sigmoidoscopy
Number of subjects: 114700

Group type: EXPERIMENTAL
Intervention: Faecal immunochemical test (FIT)
Number of subjects: 114700

Group type: EXPERIMENTAL
Intervention: Compliance to colonoscopy after positive FIT
Number of subjects: 114700
Study: 34755007

Group type: EXPERIMENTAL
Intervention: Monthly minodronate (MIN group)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Active vitamin D (VD group)
Number of subjects: 164
Study: 33324264

Group type: EXPERIMENTAL
Intervention: Vignette 1 (patient receiving MMT)
Number of subjects: 1066

Group type: COMPARATOR
Intervention: Vignette 2 (patient receiving amlodipine treatment)
Number of subjects: 1066
Study: 34875529

Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo control (PC)
Number of subjects: 40
Study: 33420819

Group type: EXPERIMENTAL
Intervention: Generic rocuronium
Number of subjects: 40

Group type: COMPARATOR
Intervention: Original rocuronium
Number of subjects: 40
Study: 35706006

Group type: EXPERIMENTAL
Intervention: Anakinra for 24 weeks
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo for 24 weeks
Number of subjects: 102
Study: 32506845

Group type: EXPERIMENTAL
Intervention: High-intensity interval training (25-min, ten one-minute intervals at 85% heart-rate reserve)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Moderate-intensity continuous training (45-min at 50% heart-rate reserve)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control day (30-min quiet rest)
Number of subjects: 9
Study: 35251557

Group type: EXPERIMENTAL
Intervention: Nursing intervention based on mobile nursing system
Number of subjects: 266

Group type: COMPARATOR
Intervention: Routine physical examination during pregnancy
Number of subjects: 266
Study: 32885229

Group type: EXPERIMENTAL
Intervention: Low-Carbohydrate Diet (LC) - <40% energy from carbohydrates
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-Fat Diet (LF) - <30% energy from fat
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Weight Loss
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Actual carbohydrate intake at the end of the study
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Actual fat intake at the end of the study
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Caloric intake changes
Number of subjects: 0
Study: 32358397

Group type: EXPERIMENTAL
Intervention: Probiotics (Bifidobacterium triplex)
Number of subjects: 60
Study: 34477175

Group type: EXPERIMENTAL
Intervention: LF rTMS + MI + active ES
Number of subjects: 17

Group type: COMPARATOR
Intervention: LF rTMS + MI + sham ES
Number of subjects: 17
Study: 32315869

Group type: EXPERIMENTAL
Intervention: Direct Oral Anticoagulants (DOAC)
Number of subjects: 241

Group type: COMPARATOR
Intervention: Vitamin K Antagonists (VKA)
Number of subjects: 241
Study: 34498307

Group type: EXPERIMENTAL
Intervention: Pomegranate extract tablets
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 33475546

Group type: EXPERIMENTAL
Intervention: OneShape file
Number of subjects: 60

Group type: COMPARATOR
Intervention: ProTaper Next rotary instrument
Number of subjects: 60
Study: 33983526

Group type: EXPERIMENTAL
Intervention: Bone Transport technique (BT)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Masquelet technique (MT)
Number of subjects: 25
Study: 35770557

Group type: EXPERIMENTAL
Intervention: Acupuncture on fifteen anxiety‐related points
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group received acupuncture on fifteen points unrelated to anxiety
Number of subjects: 20
Study: 32814640

Group type: EXPERIMENTAL
Intervention: Influenza vaccination during pregnancy
Number of subjects: 1752

Group type: COMPARATOR
Intervention: Placebo during pregnancy
Number of subjects: 1752
Study: 35931103

Group type: EXPERIMENTAL
Intervention: IMGX003 (1200 mg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 32748473

Group type: EXPERIMENTAL
Intervention: Silymarin (40 g/day)
Number of subjects: 110
Study: 36055798

Group type: EXPERIMENTAL
Intervention: o‐RUTF
Number of subjects: 129

Group type: COMPARATOR
Intervention: s‐RUTF
Number of subjects: 129
Study: 34241955

Group type: EXPERIMENTAL
Intervention: Father involvement during pregnancy and postnatal
Number of subjects: 212
Study: 32404096

Group type: EXPERIMENTAL
Intervention: 12-week multidisciplinary rehabilitation programme (supervised and self-managed exercise, dietary counselling, and education)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard survivorship care
Number of subjects: 120
Study: 35628300

Group type: EXPERIMENTAL
Intervention: DI + thigh cuff
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (only DI)
Number of subjects: 18
Study: 33355646

Group type: EXPERIMENTAL
Intervention: Pazopanib with gemcitabine (A)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Pazopanib without gemcitabine (B)
Number of subjects: 90
Study: 35918106

Group type: EXPERIMENTAL
Intervention: Daprodustat three times weekly
Number of subjects: 407

Group type: COMPARATOR
Intervention: Conventional epoetin
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Daprodustat
Number of subjects: 407

Group type: COMPARATOR
Intervention: Epoetin
Number of subjects: 407
Study: 33125769

Group type: EXPERIMENTAL
Intervention: Parathyroidectomy (PTX)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Observation without treatment (OBS)
Number of subjects: 191
Study: 34036760

Group type: EXPERIMENTAL
Intervention: Abdominal massage (I Love You method), 15 minutes before feeding, twice a day for 5 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no massage therapy)
Number of subjects: 0